Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001771207-25-000002
Filing Date
2025-12-11
Accepted
2025-12-11 16:15:10
Documents
1
Period of Report
2025-12-09

Document Format Files

Seq Description Document Type Size
1 form4-12112025_041204.html 4  
1 form4-12112025_041204.xml 4 3413
  Complete submission text file 0001771207-25-000002.txt   4900
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MILESTONE PHARMACEUTICALS, INC. 1111 DR. FREDERIK-PHILIPS BLVD., STE 420 MONTREAL A8 H4M 2X6
Business Address
Muller Lorenz (Reporting) CIK: 0001771207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38899 | Film No.: 251565149